Skip to main content

Peer Review reports

From: Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma

Original Submission
8 Jan 2023 Submitted Original manuscript
16 Feb 2024 Reviewed Reviewer Report
11 Mar 2024 Reviewed Reviewer Report
25 Mar 2024 Author responded Author comments - Renfeng Shan
Resubmission - Version 2
25 Mar 2024 Submitted Manuscript version 2
5 Apr 2024 Reviewed Reviewer Report
5 Apr 2024 Reviewed Reviewer Report
10 Apr 2024 Author responded Author comments - Renfeng Shan
Resubmission - Version 3
10 Apr 2024 Submitted Manuscript version 3
23 Apr 2024 Reviewed Reviewer Report
24 Apr 2024 Reviewed Reviewer Report
25 Apr 2024 Author responded Author comments - Renfeng Shan
Resubmission - Version 4
25 Apr 2024 Submitted Manuscript version 4
7 May 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
7 May 2024 Editorially accepted
14 May 2024 Article published 10.1186/s12885-024-12355-x

You can find further information about peer review here.

Back to article page